Status:
COMPLETED
Molecular Signatures of Esophageal Atresia
Lead Sponsor:
University Hospital, Lille
Conditions:
Esophageal Atresia
Eligibility:
All Genders
1-1 years
Phase:
NA
Brief Summary
Although several studies have revealed signaling pathways as well as genes potentially involved in the development of esophageal atresia (EA), our understanding of the pathophysiology of EA lags behin...
Eligibility Criteria
Inclusion
- Anastomosis group :
- Born with esophageal atresia Anastomosis performed in Lille hospital Parents consent
- \- Control group : Born with esophageal atresia
Exclusion
- Both groups :
- Parents refusing to participate in the study
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 4 2024
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT06073158
Start Date
September 1 2023
End Date
March 4 2024
Last Update
December 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Lille
Lille, France, 59007